...
首页> 外文期刊>Hospital pharmacy. >Warfarin Resistance and Enteral Tube Feeding: An Old Problem With a New Solution
【24h】

Warfarin Resistance and Enteral Tube Feeding: An Old Problem With a New Solution

机译:华法林抗药性和肠内饲管:新解决方案的老问题

获取原文
获取原文并翻译 | 示例
           

摘要

Warfarin resistance associated with continuous enteral tube feedings was first reported in the early 1980s.1"5 This resistance was attributed to the large amounts of vitamin K contained within the feedings. It was not uncommon for patients to receive several hundred micro-grams per day of vitamin K from the feedings. The pharmaceutical industry subsequently responded to this problem by significantly reducing the vitamin K content of the liquid enteral nutrition formulations. However, despite these efforts with vitamin K content reduction, we still periodically experienced problems of achieving therapeutic anticoagulation when warfarin was given concomitantly with continuous liquid enteral feeding or experienced significant increases in the international normalized ratio (INR) for prothrom-bin time when the enteral feeding was discontinued.
机译:与华法林连续肠管喂养有关的抗药性首次报道于1980年代初期。1“ 5这种抗药性归因于喂养中所含的大量维生素K。每天接受数百微克的患者并不罕见。饲料中维生素K的含量随之而来。制药行业随后通过显着降低液体肠内营养制剂中维生素K的含量来应对这一问题,尽管做出了这些努力以减少维生素K的含量,但我们仍然会定期遇到在实现抗凝治疗时遇到的问题与华法林同时给予肠内连续液体喂养,或中断肠内喂养时凝血酶原时间的国际标准化比率(INR)显着增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号